JP2001213778A5 - - Google Patents

Download PDF

Info

Publication number
JP2001213778A5
JP2001213778A5 JP2000025794A JP2000025794A JP2001213778A5 JP 2001213778 A5 JP2001213778 A5 JP 2001213778A5 JP 2000025794 A JP2000025794 A JP 2000025794A JP 2000025794 A JP2000025794 A JP 2000025794A JP 2001213778 A5 JP2001213778 A5 JP 2001213778A5
Authority
JP
Japan
Prior art keywords
compound
embedded image
group
hydroxyl group
hydrogen atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000025794A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001213778A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2000025794A priority Critical patent/JP2001213778A/ja
Priority claimed from JP2000025794A external-priority patent/JP2001213778A/ja
Publication of JP2001213778A publication Critical patent/JP2001213778A/ja
Publication of JP2001213778A5 publication Critical patent/JP2001213778A5/ja
Pending legal-status Critical Current

Links

JP2000025794A 2000-02-03 2000-02-03 負荷ストレス軽減剤及びそれを含有する皮膚外用剤 Pending JP2001213778A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2000025794A JP2001213778A (ja) 2000-02-03 2000-02-03 負荷ストレス軽減剤及びそれを含有する皮膚外用剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000025794A JP2001213778A (ja) 2000-02-03 2000-02-03 負荷ストレス軽減剤及びそれを含有する皮膚外用剤

Publications (2)

Publication Number Publication Date
JP2001213778A JP2001213778A (ja) 2001-08-07
JP2001213778A5 true JP2001213778A5 (https=) 2007-03-15

Family

ID=18551602

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000025794A Pending JP2001213778A (ja) 2000-02-03 2000-02-03 負荷ストレス軽減剤及びそれを含有する皮膚外用剤

Country Status (1)

Country Link
JP (1) JP2001213778A (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002078685A1 (en) * 2001-03-30 2002-10-10 The Nisshin_Oillio, Ltd. Drugs for vascular lesion
FR2829390B1 (fr) * 2001-09-12 2005-08-19 Rocher Yves Biolog Vegetale Utilisation d'un extrait de shiitake dans des compositions cosmetiques pour le soin de la peau
US20050143464A1 (en) * 2003-09-22 2005-06-30 Use-Techno Corporation Insulin secretion potentiator
CN1913888A (zh) * 2003-12-18 2007-02-14 荷兰联合利华有限公司 降低应激对皮肤调理的作用的方法
JP4938302B2 (ja) * 2005-12-12 2012-05-23 ポーラ化成工業株式会社 皮膚バリア機能向上のための皮膚外用剤
JP4980634B2 (ja) * 2006-03-17 2012-07-18 ポーラ化成工業株式会社 肌荒れの予防、改善に好適な皮膚外用剤
TWI413646B (zh) 2010-09-03 2013-11-01 Univ China Medical 用於抑制基質金屬蛋白酶活性及／或生成、抑制有絲分裂原活化蛋白激酶磷酸化、及／或促進膠原蛋白生成之醫藥組合物及其用途
JP2015189691A (ja) * 2014-03-27 2015-11-02 公益財団法人東洋食品研究所 Ｇｐｄｈ活性抑制剤
JP2022006397A (ja) * 2020-06-24 2022-01-13 丸善製薬株式会社 バリア機能亢進剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61205204A (ja) * 1985-03-08 1986-09-11 Shiseido Co Ltd 皮膚外用剤
US5232693A (en) * 1992-03-09 1993-08-03 Dow Corning Corporation Method of treating dry skin
JP3542635B2 (ja) * 1994-05-23 2004-07-14 ポーラ化成工業株式会社 代謝活性化剤及び皮膚外用剤並びに浴用剤
JP3458041B2 (ja) * 1995-09-19 2003-10-20 ポーラ化成工業株式会社 光老化防止剤及び皮膚化粧料
US6245443B1 (en) * 1996-08-28 2001-06-12 Norton Company Removable bond for abrasive tool

Similar Documents

Publication Publication Date Title
US5780460A (en) Therapeutic methods and delivery systems utilizing sex steroid precursors
CA2326654A1 (en) Use of steroidal alkaloid derivatives as inhibitors of hedgehog signaling pathways
US5807849A (en) Therapeutic methods and delivery systems utilizing sex steroid precursors
Wheeler The Girard Reagents.
FR2884713A1 (fr) Kit steroidique et composition pouvant mousser et utilisation de ceux-ci
JP2008536851A5 (ja) 女性でテストステロンおよび関連ステロイドの濃度を増加させる医薬組成物および医薬キット
JP2001213778A5 (https=)
AU2003251636B2 (en) Composition containing an androgenous 11beta-halogen steroid and a progestational hormone, and male contraceptive based on said composition
WO1998026783A1 (fr) Utilisations des composes antiglucocorticoides pour le traitement des psychoses et des comportements addictifs
JPH0132235B2 (https=)
JP2001515488A (ja) ７−ヒドロキシ化されたステロイドの化粧用または皮膚科学用使用
JP2001213775A5 (https=)
JP2001213778A (ja) 負荷ストレス軽減剤及びそれを含有する皮膚外用剤
JP4450435B2 (ja) Ｐｍｓおよび不安の症状を緩和する、ｖｎｏにおける神経化学刺激物質としてのステロイド
JPS60161998A (ja) １α，２α―メチレン―６―メチレン―又は―６α―メチル―プレグネン及びその製法
Potts et al. Dissociation of the androgenic and other hormonal activities from the protein anabolic effects of steroids
EP2925770B1 (en) 3-(4'-substituted)-benzyl-ether derivatives of pregnenolone
RS50740B (sr) Androgeni 7-supstituisani 11-halogenovani steroidi
US3228837A (en) Oral anabolic composition and method of use
EP1666044A1 (en) Male contraceptive formulation comprising norethisterone
Brown et al. Further studies on the erythrocyte anti-inflammatory assay
EP1462107B1 (en) Method of female contraception and kit for use in such method
JPH0610127B2 (ja) 養毛料
JP2004520411A5 (https=)
Ruppert et al. The role of aromatization in the development of sexual behavior of the female hamster (Mesocricetus auratus)